Spero Therapeutics, Inc. (SPRO) Social Stream



Spero Therapeutics, Inc. (SPRO): $15.11

-0.88 (-5.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Spero Therapeutics Inc (SPRO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Spero Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $47 $25 $34.75 $16.1 115.84%

The Trend in the Analyst Price Target


Over the past 30 weeks, SPRO's average price target has gone up $1.75.

SPRO reports an average of 105.98% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-15 5 47 25 34.75 16.41 111.76%
2020-05-30 NA 28 7 20.60 NA NA%

SPRO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


SPRO's average broker recommendation rating improved by 0.1 over the prior 61 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SPRO has a higher upside potential (average analyst target price relative to current price) than 85.82% of all US stocks.
  • Spero Therapeutics Inc's variance in analysts' estimates is lower than 16.52% of all US stocks.
  • Spero Therapeutics Inc's average analyst price target is higher than 74.12% of stocks in the small market cap category.
  • The number of analysts covering the stock of SPRO is higher than 71.36% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Spero Therapeutics Inc are DTIL, VXRT and ZYNE.

Is SPRO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6872 seconds.